Gene: ZNF559
Official Full Name: zinc finger protein 559provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24815 | ZNF559 Knockout cell line (HeLa) | Human | ZNF559 | 1:3~1:6 | Negative | Online Inquiry |
KO24816 | ZNF559 Knockout cell line (HCT 116) | Human | ZNF559 | 1:2~1:4 | Negative | Online Inquiry |
KO24817 | ZNF559 Knockout cell line (HEK293) | Human | ZNF559 | 1:3~1:6 | Negative | Online Inquiry |
KO24818 | ZNF559 Knockout cell line (A549) | Human | ZNF559 | 1:3~1:4 | Negative | Online Inquiry |
ZNF559 Gene Knockout Cell Lines are meticulously engineered cell lines in which the ZNF559 gene has been inactivated through the CRISPR-Cas9 gene-editing technology. This innovative product allows researchers to study the gene's role in various biological processes, including cellular signaling, gene expression regulation, and development. By creating a knockout model, scientists can analyze the phenotypic consequences of the loss of ZNF559 function, thereby elucidating its contributions to both normal physiology and disease states.
The key mechanism underlying the functionality of these knockout cell lines stems from the precise disruption of the ZNF559 gene, which encodes a member of the zinc finger protein family known to be involved in transcriptional regulation. The absence of this gene provides a valuable platform for investigating its downstream effects, particularly in pathological conditions such as cancer, where aberrant gene expression patterns are often observed. The ability to assess cellular behavior, viability, differentiation, and interaction with other signaling pathways in real-time forms the crux of its utility in research.
In clinical and research settings, ZNF559 knockout cell lines are essential for advancing our understanding of gene function and developing targeted therapeutic strategies. They enable drug efficacy and toxicity assessments, facilitating biomarker discovery and evaluation of patient-specific treatment approaches. Moreover, these cell lines offer a significant advantage over traditional models by providing a more accurate representation of human gene function, thus bridging the gap between in vitro studies and clinical relevance.
What sets our ZNF559 Gene Knockout Cell Lines apart from alternative products is the stringent quality control and validation processes we employ to ensure the specificity and reliability of the knockout. Our cells are accompanied by robust characterization data, allowing researchers to commence their experiments with confidence in the biological accuracy of their models.
In choosing our ZNF559 Gene Knockout Cell Lines, researchers and clinicians gain access to a sophisticated tool that enhances the potential for groundbreaking discoveries in gene function, disease mechanisms, and therapeutic interventions. Backed by our commitment to excellence and extensive expertise in genetic engineering, we offer scientifically robust products that propel your research forward and amplify your potential for impactful scientific contributions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.